3 résultats
FIELD
The present disclosure relates to the field of cannabinoid receptors and, in particular, to methods of regulating cannabinoid (CB) receptor activity-related disorders and diseases, such as activating CB receptors, including treating a disorder or disease, such as a glioblastoma, hepatocellular
FIELD
The present disclosure relates to the field of cannabinoid receptors and, in particular, to methods of regulating cannabinoid (CB) receptor activity-related disorders and diseases, such as activating CB receptors, including treating a disorder or disease, such as a glioblastoma, hepatocellular
RELATED APPLICATION
This application is a national stage filing under 35 U.S.C. .sctn. 371 of International Application No. PCT/GB2015/051876, filed Jun. 26, 2015, which was published under PCT Article 21(2) in English, the entire contents of which are hereby incorporated by reference.
The present